robaxin® and robaxin®-750 are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

robaxin® (methocarbamol), 500 mg – Adults:

Initial dosage: 3 tablets q.i.d.

Maintenance dosage: 2 tablets q.i.d.

robaxin®-750 (methocarbamol): 750 mg – Adults:

Initial dosage: 2 tablets q.i.d.

Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d.

Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.

robaxin® (methocarbamol tablets, USP)

500 mg tablets are light orange, round, film-coated tablets engraved with ROBAXIN 500 on the unscored side and SP above the score on the other side. They are supplied as follows:

Bottles of 100                                   NDC 0091-7429-63

robaxin®-750 (methocarbamol tablets, USP)

750 mg tablets are orange, capsule-shaped, film-coated tablets engraved with ROBAXIN 750 on one side and SP on the other. They are supplied as follows:

Bottles of 100                                   NDC 0091-7449-63

Bottles of 500                                   NDC 0091-7449-70

Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F). Dispense in tight container.

SCHWARZ PHARMA
Rev. 09/03
FDA rev date: 5/1/2003

Bookmark this page: